<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03303118</url>
  </required_header>
  <id_info>
    <org_study_id>2017-00752</org_study_id>
    <nct_id>NCT03303118</nct_id>
  </id_info>
  <brief_title>The Effects of Hypobaria vs Hypoxia on Cerebral Functions.</brief_title>
  <acronym>Hypoxia</acronym>
  <official_title>The Effects of Hypobaria vs Hypoxia on Cerebral Vasoreactivity, Brain's Electrical Activity and Concentration Performance on Pilots.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fliegerärztliches Institut</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fliegerärztliches Institut</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will investigate the effect of hypobaria and hypoxia on physiological&#xD;
      responses such as: oxygen saturation, heart rate, cerebral blood flow, cerebral oxygenation,&#xD;
      brain's activity and concentration performance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main goal of this project is to investigate how hypoxia affects cognitive functions. The&#xD;
      KLT-R test asses the concentration level of a person. Subjects will do this test at different&#xD;
      simulated altitude level in the hypobaric chamber at the FAI in Dübendorf. Investigators'&#xD;
      first hypothesis is that concentration level will be altered by hypoxia. The higher altitude&#xD;
      the subjects are, the more the concentration would be altered. KLT-R performance would be&#xD;
      impaired by hypoxia compare to sea level performance.&#xD;
&#xD;
      The primary endpoint of this project is to investigate how KLT-R performance is affected by&#xD;
      the different hypoxic conditions. KLT-R test will be passed nine times in total during the&#xD;
      test visit. There will be a pre-test; a test at each of the conditions (3000m HH, 5500m HH,&#xD;
      5500m NH and 5500m HN); between each condition at sea level (to have a new baseline before&#xD;
      each condition) and a post-test at the end of the protocol. To avoid influence of fatigue,&#xD;
      all conditions will be randomized.&#xD;
&#xD;
      The second endpoint of this study is how the brain electrical activity is modulated by&#xD;
      hypoxia. Micro-states also will be measure during hypobaric hypoxia conditions (3000m HH and&#xD;
      5500m HH).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 16, 2017</start_date>
  <completion_date type="Actual">March 5, 2018</completion_date>
  <primary_completion_date type="Actual">March 5, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single-Blind study.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration performance</measure>
    <time_frame>4 minutes per test</time_frame>
    <description>Performance of concentration at different altitude levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EEG micro-states</measure>
    <time_frame>5 minutes per record</time_frame>
    <description>5 minutes recording in each conditions, eyes closed, at rest.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cerebral vaso-reactivity</measure>
    <time_frame>8 Minutes per test</time_frame>
    <description>Cerebral vasoreactivity after 1 minute hyperventilation and 3 minutes breathing of 5% CO2 mixture.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Cerebral Hypoxia</condition>
  <arm_group>
    <arm_group_label>Left</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No product administration will be done in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxia</intervention_name>
    <description>No drug or product will be used in this study. No medication will be give to the participants. No arm will be used for product administration.</description>
    <arm_group_label>Left</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No history of flight sickness&#xD;
&#xD;
          -  No relevant medical diseases&#xD;
&#xD;
          -  Age 18 - 40 years&#xD;
&#xD;
          -  Written consent acceptance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known pathologies&#xD;
&#xD;
          -  Relevant medical disorders&#xD;
&#xD;
          -  Drug addiction&#xD;
&#xD;
          -  Anemia or poor health&#xD;
&#xD;
          -  People who have already had problems with elevation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mathias Aebi</name>
      <address>
        <city>Dübendorf</city>
        <state>Zürich</state>
        <zip>8600</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 2, 2017</study_first_submitted>
  <study_first_submitted_qc>October 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2017</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fliegerärztliches Institut</investigator_affiliation>
    <investigator_full_name>Mathias Aebi, PhD</investigator_full_name>
    <investigator_title>Dr. med Denis Bron</investigator_title>
  </responsible_party>
  <keyword>Hypoxia</keyword>
  <keyword>Brain</keyword>
  <keyword>Cerebral vaso-reactivity</keyword>
  <keyword>EEG</keyword>
  <keyword>Concentration performance</keyword>
  <keyword>Cerebral oxygenation</keyword>
  <keyword>Cerebral blood-flow</keyword>
  <keyword>Heart rate variability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia, Brain</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Results will be shared in scientific publications by the end of this year and in 2018.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

